Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Prescription Drugs

PUBLISHER: Grand View Research | PRODUCT CODE: 2089702

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2089702

Long-acting Injectables Therapeutics Market Size, Share & Trends Analysis Report By Therapeutic Area, By Molecule Type, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Long-acting Injectables Therapeutics Market Summary

The global long-acting injectables therapeutics market size was valued at USD 18.3 billion in 2025 and is projected to grow from USD 20.5 billion to USD 47.7 billion by 2033, at a CAGR of 12.8% from 2026 to 2033. North America held the largest share of 41.8% of the global market in 2025. The LAI therapeutics market is evolving into a prominent segment within advanced drug delivery systems, driven by the growing need for sustained-release treatment options across chronic and complex diseases.

Initially concentrated in the management of psychiatric disorders, particularly schizophrenia, LAIs have progressively gained traction as a broader therapeutic approach that enhances patient adherence and reduces the frequency of dosing.

This shift reflects a wider industry movement toward patient-centric care models, where treatment convenience and long-term disease control are prioritized alongside clinical efficacy. As healthcare systems continue to emphasize outcomes-based care, LAIs are increasingly being recognized as a strategic solution to address medication non-compliance and improve overall treatment continuity.

The industry is experiencing significant expansion beyond its traditional psychiatric applications, with growing adoption in infectious diseases, oncology support therapies, and hormonal treatments. Advancements in drug delivery technologies, including microsphere-based formulations, biodegradable depots, and long-acting biologics, are enabling extended dosing intervals ranging from weeks to several months. This technological progress is facilitating the development of next-generation therapies that offer improved pharmacokinetic profiles and reduced treatment burden. Pharmaceutical companies are actively investing in pipeline expansion and formulation innovation, supporting the transition of LAIs into a multi-therapeutic platform with increasing clinical and commercial relevance across global healthcare markets.

The LAI therapeutics industry is characterized by rising investments in research and development, strategic collaborations, and growing emphasis on lifecycle management of injectable products. While pricing and reimbursement challenges remain key considerations due to the premium nature of these therapies, their value proposition is strengthened by reduced hospitalization rates and improved patient outcomes. The market is further supported by expanding clinical evidence and regulatory interest in long-acting formulations, positioning LAIs as a critical component of future drug delivery strategies. Overall, the market is moving toward sustained growth, underpinned by innovation, therapeutic diversification, and increasing global demand for adherence-focused treatment solutions.

Global Long-acting Injectables Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global long-acting injectables therapeutics market report based on therapeutic area, molecule type, route of administration, distribution channel, and region:

  • Therapeutic Area Outlook (Revenue, USD Billion, 2021 - 2033)
  • Central Nervous System (CNS) Disorders
  • Infectious Diseases
  • Metabolic & Endocrine Disorders
  • Oncology
  • Autoimmune & Inflammatory Diseases
  • Other Therapeutic Areas
  • Molecule Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Small Molecules
  • Biologics
  • Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospital Pharmacies
  • Specialty Pharmacies
  • Retail Pharmacies
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-932-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Therapeutic Area
    • 1.2.2. Molecule Type
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Long-acting Injectables Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Long-acting Injectables Therapeutics Market: Therapeutic Area Business Analysis

  • 4.1. Therapeutic Area Market Share, 2025 & 2033
  • 4.2. Therapeutic Area Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Billion)
  • 4.4. Central Nervous System (CNS) Disorders
    • 4.4.1. Central Nervous System (CNS) Disorders Market, 2021 - 2033 (USD Billion)
  • 4.5. Infectious Diseases
    • 4.5.1. Infectious Diseases Market, 2021 - 2033 (USD Billion)
  • 4.6. Metabolic & Endocrine Disorders
    • 4.6.1. Metabolic & Endocrine Disorders Market, 2021 - 2033 (USD Billion)
  • 4.7. Oncology
    • 4.7.1. Oncology Market, 2021 - 2033 (USD Billion)
  • 4.8. Autoimmune & Inflammatory Diseases
    • 4.8.1. Autoimmune & Inflammatory Diseases Market, 2021 - 2033 (USD Billion)
  • 4.9. Other Therapeutic Areas
    • 4.9.1. Other Therapeutic Areas Market, 2021 - 2033 (USD Billion)

Chapter 5. Long-acting Injectables Therapeutics Market: Molecule Type Business Analysis

  • 5.1. Molecule Type Market Share, 2025 & 2033
  • 5.2. Molecule Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Molecule Type, 2021 to 2033 (USD Billion)
  • 5.4. Small Molecules
    • 5.4.1. Small Molecules Market, 2021 - 2033 (USD Billion)
  • 5.5. Biologics
    • 5.5.1. Biologics Market, 2021 - 2033 (USD Billion)

Chapter 6. Long-acting Injectables Therapeutics Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2025 & 2033
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion)
  • 6.4. Intramuscular (IM)
    • 6.4.1. Intramuscular (IM) Market, 2021 - 2033 (USD Billion)
  • 6.5. Subcutaneous (SC)
    • 6.5.1. Subcutaneous (SC) Market, 2021 - 2033 (USD Billion)

Chapter 7. Long-acting Injectables Therapeutics Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2025 & 2033
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution channel, 2021 to 2033 (USD Billion)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.5. Specialty Pharmacies
    • 7.5.1. Specialty Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.6. Retail Pharmacies
    • 7.6.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)

Chapter 8. Long-acting Injectables Therapeutics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Long-acting Injectables Therapeutics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Framework
      • 8.4.2.5. U.S. Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Framework
      • 8.4.3.5. Canada Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Framework
      • 8.4.4.5. Mexico Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5. Europe
    • 8.5.1. Europe Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Framework
      • 8.5.2.5. UK Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Framework
      • 8.5.3.5. Germany Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Framework
      • 8.5.4.5. France Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Framework
      • 8.5.5.5. Italy Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Framework
      • 8.5.6.5. Spain Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Framework
      • 8.5.7.5. Denmark Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Target Disease Prevalence
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement Framework
      • 8.5.8.5. Sweden Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Target Disease Prevalence
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement Framework
      • 8.5.9.5. Norway Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Framework
      • 8.6.2.5. Japan Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Framework
      • 8.6.3.5. China Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Framework
      • 8.6.4.5. India Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Framework
      • 8.6.5.5. Australia Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement Framework
      • 8.6.6.5. South Korea Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Target Disease Prevalence
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement Framework
      • 8.6.7.5. Thailand Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Latin America Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Framework
      • 8.7.2.5. Brazil Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Framework
      • 8.7.3.5. Argentina Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Target Disease Prevalence
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement Framework
      • 8.8.2.5. South Africa Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Target Disease Prevalence
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement Framework
      • 8.8.3.5. Saudi Arabia Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Target Disease Prevalence
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement Framework
      • 8.8.4.5. UAE Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Target Disease Prevalence
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement Framework
      • 8.8.5.5. Kuwait Long-acting Injectables Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Johnson & Johnson
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Gilead Sciences
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Eli Lilly and Company
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. AstraZeneca
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Otsuka Pharmaceutical
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Lundbeck
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Pfizer
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Takeda Pharmaceutical Company
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Novartis AG
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-932-2

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global long-acting injectables therapeutics market, by region, 2021 - 2033 (USD Billion)
  • Table 4 Global long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 5 Global long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 6 Global long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 7 Global long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 8 North America long-acting injectables therapeutics market, by country, 2021 - 2033 (USD Billion)
  • Table 9 North America long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 10 North America long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 11 North America long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 12 North America long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 13 U.S. long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 14 U.S. long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 15 U.S. long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 16 U.S. long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 17 Canada long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 18 Canada long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 19 Canada long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 20 Canada long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 21 Mexico long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 22 Mexico long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 23 Mexico long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 24 Mexico long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 25 Europe long-acting injectables therapeutics market, by country, 2021 - 2033 (USD Billion)
  • Table 26 Europe long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 27 Europe long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 28 Europe long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 29 Europe long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 30 UK long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 31 UK long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 32 UK long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 33 UK long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 34 Germany long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 35 Germany long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 36 Germany long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 37 Germany long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 38 France long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 39 France long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 40 France long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 41 France long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 42 Italy long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 43 Italy long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 44 Italy long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 45 Italy long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 46 Spain long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 47 Spain long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 48 Spain long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 49 Spain long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 50 Norway long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 51 Norway long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 52 Norway long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 53 Norway long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 54 Denmark long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 55 Denmark long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 56 Denmark long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 57 Denmark long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 58 Sweden long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 59 Sweden long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 60 Sweden long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 61 Sweden long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 62 Asia Pacific long-acting injectables therapeutics market, by country, 2021 - 2033 (USD Billion)
  • Table 63 Asia Pacific long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 64 Asia Pacific long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 65 Asia Pacific long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 66 Asia Pacific long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 67 Japan long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 68 Japan long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 69 Japan long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 70 Japan long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 71 China long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 72 China long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 73 China long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 74 China long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 75 India long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 76 India long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 77 India long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 78 India long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 79 Australia long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 80 Australia long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 81 Australia long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 82 Australia long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 83 South Korea long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 84 South Korea long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 85 South Korea long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 86 South Korea long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 87 Thailand long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 88 Thailand long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 89 Thailand long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 90 Thailand long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 91 Latin America long-acting injectables therapeutics market, by country, 2021 - 2033 (USD Billion)
  • Table 92 Latin America long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 93 Latin America long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 94 Latin America long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 95 Latin America long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 96 Brazil long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 97 Brazil long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 98 Brazil long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 99 Brazil long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 100 Argentina long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 101 Argentina long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 102 Argentina long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 103 Argentina long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 104 Middle East & Africa long-acting injectables therapeutics market, by country, 2021 - 2033 (USD Billion)
  • Table 105 Middle East & Africa long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 106 Middle East & Africa long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 107 Middle East & Africa long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 108 Middle East & Africa long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 109 South Africa long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 110 South Africa long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 111 South Africa long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 112 South Africa long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 113 Saudi Arabia long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 114 Saudi Arabia long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 115 Saudi Arabia long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 116 Saudi Arabia long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 117 UAE long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 118 UAE long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 119 UAE long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 120 UAE long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 121 Kuwait long-acting injectables therapeutics market, by therapeutic area, 2021 - 2033 (USD Billion)
  • Table 122 Kuwait long-acting injectables therapeutics market, by molecule type, 2021 - 2033 (USD Billion)
  • Table 123 Kuwait long-acting injectables therapeutics market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 124 Kuwait long-acting injectables therapeutics market, by distribution channel, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Long-acting injectables therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Long-acting injectables therapeutics market dynamics
  • Fig. 11 Long-acting injectables therapeutics market: Porter's five forces analysis
  • Fig. 12 Long-acting injectables therapeutics market: PESTLE analysis
  • Fig. 13 Therapeutic area market, 2021 - 2033 (USD Billion)
  • Fig. 14 Central nervous system (CNS) disorders market, 2021 - 2033 (USD Billion)
  • Fig. 15 Infectious diseases market, 2021 - 2033 (USD Billion)
  • Fig. 16 Metabolic & endocrine disorders market, 2021 - 2033 (USD Billion)
  • Fig. 17 Oncology market, 2021 - 2033 (USD Billion)
  • Fig. 18 Autoimmune & inflammatory diseases market, 2021 - 2033 (USD Billion)
  • Fig. 19 Other therapeutic areas market, 2021 - 2033 (USD Billion)
  • Fig. 20 Molecule type market, 2021 - 2033 (USD Billion)
  • Fig. 21 Small molecules market, 2021 - 2033 (USD Billion)
  • Fig. 22 Biologics market, 2021 - 2033 (USD Billion)
  • Fig. 23 Route of administration market, 2021 - 2033 (USD Billion)
  • Fig. 24 Intramuscular (IM) market, 2021 - 2033 (USD Billion)
  • Fig. 25 Subcutaneous (SC) market, 2021 - 2033 (USD Billion)
  • Fig. 26 Distribution channel market, 2021 - 2033 (USD Billion)
  • Fig. 27 Hospital pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 28 Specialty pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 29 Retail pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 30 Long-acting injectables therapeutics market revenue, by region
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 39 Europe Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 44 France country dynamics
  • Fig. 45 France Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 50 Norway country dynamics
  • Fig. 51 Norway Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 54 Denmark country dynamics
  • Fig. 55 Denmark Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 56 Asia Pacific Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 59 China country dynamics
  • Fig. 60 China Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 61 India country dynamics
  • Fig. 62 India Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 69 Latin America Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 74 MEA Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait Long-acting injectables therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!